MULTIPLE SCLEROSIS IN 2010 Advances in monitoring and treatment of multiple sclerosis

被引:5
|
作者
Filippi, Massimo [1 ,2 ]
机构
[1] Inst Sci, Div Neurosci, Inst Expt Neurol, Neuroimaging Res Unit, I-20132 Milan, Italy
[2] Univ Hosp San Raffaele, I-20132 Milan, Italy
关键词
PLACEBO-CONTROLLED TRIAL; NEUTRALIZING ANTIBODIES; DIAGNOSTIC-CRITERIA; INTERFERON-BETA; ORAL FINGOLIMOD;
D O I
10.1038/nrneurol.2010.215
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
2010 represented a milestone in the history of multiple sclerosis monitoring and treatment. MRI and immunological biomarkers were identified to track disease evolution and, ultimately, to guide treatment decisions. moreover, oral disease-modifying therapies emerged that should increase treatment regimen adherence and improve patient outcomes.
引用
收藏
页码:74 / 75
页数:2
相关论文
共 50 条